Toronto, Ontario--(Newsfile Corp. - August 4, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (OTCQB: TRUFF) (FSE: 4YX) ("Rhelion" or the "Company") is pleased to announce that it has completed its corporate name change from Red Light Holland Corp. to Rhelion Life Sciences Corp. and changed its ticker symbol on the Canadian Securities Exchange (the "CSE") from "TRIP" to "RHEL" (collectively, the "Name and Ticker Change"). Todd Shapiro, Chief Executive Officer and Director of Rhelion Life Sciences, commented:"Today marks an exciting milestone in our Company's evolution. We believe the Rhelion name better reflects who we are today and where we are headed as a science-focused life sciences company." ABOUT RHELION LIFE SCIENCES CORP.Rhelion is a science and research led company advancing the natural psychedelic drug discovery and development sector. To view the source version of this press release, please visit https://www.newsfilecorp.com/release/308070Source: Rhelion Life Sciences Corp.